Zacks Investment Research
12 Oct 2026, 13:55 UTC · 2h ago
Impact · against what's priced in
Vera Bradley (VRA) shows strong positive momentum and favorable earnings revisions, but the news is largely reflective of the stock's recent 63.7% price surge. The article serves as a confirmation of existing trends rather than a new catalyst.
No priced-in read yet
What the story claims
3 claims · scored −1 bearish … +1 bullish · 0 new · 3 priced in
Vera Bradley (VRA) has a Zacks Rank #1 due to an upward trend in earnings estimate revisions.
Priced inanalysis piece discussing stock rank
So whatA Rank #1 typically correlates with outperforming the market over the next 1-3 months.
More positive than 79% of claims this week
VRA's stock price increased by 63.7% over the last four weeks and 37.1% over the last 12 weeks.
Continue reading
5 related stories
The stock has seen significant recent momentum, rising 63.7% over four weeks, which aligns with its Zacks Rank #1 status and upward earnings revisions.
Read from the article alone
Scored by the NIS engine · methodology.
Search tags
Priced inanalysis of historical price action
More positive than 54% of claims this week
Vera Bradley currently has a beta of 1.5.
Priced inanalysis of stock volatility
So whatHigh beta suggests the stock will amplify market swings by 50%, increasing portfolio volatility.
More positive than 44% of claims this week
Which stocks this story touches
More positive than 99% of ticker scores this week
The company is highlighted as a 'great candidate' with a Zacks Rank #1, strong price momentum, and upward earnings revisions.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Zacks Investment Research
2h ago
+2.1%
Price agrees with the score
$5.25 vs $5.14 close before publication (Oct 9) · not market-adjusted
VRA chart →
